Back to top

Dianthus initiates EMERGE trial of claseprubart

Dianthus (DNTH) announced initiation of the Phase 3 EMERGE trial of claseprubart in generalized Myasthenia Gravis. EMERGE is a global, randomized, ...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Dianthus Therapeutics, Inc. (DNTH)